Investor Presentaiton

Global leader in Targeted Copper Theranostics Clarity's SAR Technology is used to develop the next generation of radiopharmaceuticals that employ the "perfect pairing" of copper-64 (64Cu) for diagnosis and copper-67 (67Cu) for therapy Diagnostic Positron emission from 64Cu at the tumour site enables better diagnosis through PET imaging Therapeutic Beta particle (B-) emission from 67Cu delivers radiation directly to the cancer cells in order to kill them CLARITY 2014 MEIE 64CU SARTATE™M 64CU SARTATE™M PET screening 4 hours 67CU SARTATE™M SPECT scan 24 hours 67 CU SARTATE™M | | Both diagnostics and therapeutics target the same cancer sites with high accuracy and precision, delivering a key platform advantage 6

View entire presentation